Mucopolysaccharidosis Type I: A Review of the Natural History and Molecular Pathology.

作者: Christiane S. Hampe , Julie B. Eisengart , Troy C. Lund , Paul J. Orchard , Monika Swietlicka

DOI: 10.3390/CELLS9081838

关键词:

摘要: Mucopolysaccharidosis type I (MPS I) is a rare autosomal recessive inherited disease, caused by deficiency of the enzyme α-L-iduronidase, resulting in accumulation glycosaminoglycans (GAGs) dermatan and heparan sulfate organs tissues. If untreated, patients with severe phenotype die within first decade life. Early diagnosis crucial to prevent development fatal disease manifestations, prominently cardiac respiratory as well cognitive impairment. However, initial symptoms are nonspecific impede early diagnosis. This review discusses common phenotypic manifestations order which they develop. Similarities differences three animal models for MPS highlighted. Earliest symptoms, present during 6 months life, include hernias, coarse facial features, recurrent rhinitis and/or upper airway obstructions absence infection, thoracolumbar kyphosis. During next months, loss hearing, corneal clouding, further musculoskeletal dysplasias Finally, late including lower decline emerge. Cardiac can develop infancy. The underlying pathogenesis intra- extracellular partially degraded GAGs infiltration cells enlarged lysosomes causing tissue expansion bone deformities. These interfere proper arrangement collagen fibrils, disrupt nerve fibers, cause devastating secondary pathophysiological cascades inflammation, oxidative stress, other disruptions intracellular homeostasis. A greater understanding natural history will allow timely management facilitating better treatment outcomes.

参考文章(230)
P. A. Schachern, D. A. Shea, M. M. Paparella, Mucopolysaccharidosis I-H (Hurler's Syndrome) and Human Temporal Bone Histopathology: Annals of Otology, Rhinology, and Laryngology. ,vol. 93, pp. 65- 69 ,(1984) , 10.1177/000348948409300115
Douglas R. Keene, James D. San Antonio, Richard Mayne, David J. McQuillan, George Sarris, Samuel A. Santoro, Renato V. Iozzo, Decorin binds near the C terminus of type I collagen. Journal of Biological Chemistry. ,vol. 275, pp. 21801- 21804 ,(2000) , 10.1074/JBC.C000278200
Janna K. Mouw, Guanqing Ou, Valerie M. Weaver, Extracellular matrix assembly: a multiscale deconstruction Nature Reviews Molecular Cell Biology. ,vol. 15, pp. 771- 785 ,(2014) , 10.1038/NRM3902
Charles H. Vite, Ping Wang, Reema T. Patel, Raquel M. Walton, Steven U. Walkley, Rani S. Sellers, N. Matthew Ellinwood, Alphonsus S. Cheng, Joleen T. White, Charles A. O'Neill, Mark Haskins, Biodistribution and pharmacodynamics of recombinant human alpha-l-iduronidase (rhIDU) in mucopolysaccharidosis type I-affected cats following multiple intrathecal administrations Molecular Genetics and Metabolism. ,vol. 103, pp. 268- 274 ,(2011) , 10.1016/J.YMGME.2011.03.011
Kim M. Newkirk, Rosalie M. Atkins, Patti I. Dickson, Barton W. Rohrbach, Michael F. McEntee, Ocular lesions in canine mucopolysaccharidosis I and response to enzyme replacement therapy. Investigative Ophthalmology & Visual Science. ,vol. 52, pp. 5130- 5135 ,(2011) , 10.1167/IOVS.10-6751
Jonathan M. Heppner, Frank Zaucke, Lorne A. Clarke, Extracellular matrix disruption is an early event in the pathogenesis of skeletal disease in mucopolysaccharidosis I. Molecular Genetics and Metabolism. ,vol. 114, pp. 146- 155 ,(2015) , 10.1016/J.YMGME.2014.09.012
John M. Whitelock, Renato V. Iozzo, Heparan sulfate: a complex polymer charged with biological activity. Chemical Reviews. ,vol. 105, pp. 2745- 2764 ,(2005) , 10.1021/CR010213M
Derbis Campos, Madelyn Monaga, Mucopolysaccharidosis type I: current knowledge on its pathophysiological mechanisms. Metabolic Brain Disease. ,vol. 27, pp. 121- 129 ,(2012) , 10.1007/S11011-012-9302-1